| Year |
Citation |
Score |
| 2023 |
Aburahma A, Rana S, Larsen R, Ward CS, Sprague JE. Influence of adrenalectomy on the gut microbiome and MDMA-induced hyperthermia. European Journal of Pharmacology. 945: 175643. PMID 36882148 DOI: 10.1016/j.ejphar.2023.175643 |
0.309 |
|
| 2011 |
Hrometz SL, Thatcher KE, Ebert JA, Mills EM, Sprague JE. Identification of a possible role for atrial natriuretic peptide in MDMA-induced hyperthermia. Toxicology Letters. 206: 234-7. PMID 21827841 DOI: 10.1016/J.Toxlet.2011.07.025 |
0.429 |
|
| 2011 |
Banks ML, Sprague JE. From Bench to Bedside: Understanding the Science behind the Pharmacologic Management of MDMA- and other Sympathomimetic-Mediated Hyperthermia Journal of Pharmacy Technology. 27: 123-131. DOI: 10.1177/875512251102700305 |
0.31 |
|
| 2009 |
Banks ML, Buzard SK, Gehret CM, Monroy AN, Kenaston MA, Mills EM, Sprague JE. Pharmacodynamic characterization of insulin on MDMA-induced thermogenesis. European Journal of Pharmacology. 615: 257-61. PMID 19482019 DOI: 10.1016/J.Ejphar.2009.05.021 |
0.319 |
|
| 2009 |
Wyeth RP, Mills EM, Ullman A, Kenaston MA, Burwell J, Sprague JE. The hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) is sensitive to sex differences. Toxicology and Applied Pharmacology. 235: 33-8. PMID 19121330 DOI: 10.1016/J.Taap.2008.12.003 |
0.31 |
|
| 2008 |
Banks ML, Czoty PW, Sprague JE, Nader MA. Influence of thyroid hormones on 3,4-methylenedioxymethamphetamine-induced thermogenesis and reinforcing strength in monkeys. Behavioural Pharmacology. 19: 167-70. PMID 18332682 DOI: 10.1097/Fbp.0B013E3282F62C40 |
0.385 |
|
| 2008 |
Banks ML, Sprague JE, Czoty PW, Nader MA. Effects of ambient temperature on the relative reinforcing strength of MDMA using a choice procedure in monkeys. Psychopharmacology. 196: 63-70. PMID 17899019 DOI: 10.1007/S00213-007-0932-7 |
0.345 |
|
| 2007 |
Banks ML, Sprague JE, Kisor DF, Czoty PW, Nichols DE, Nader MA. Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeys. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 35: 1840-5. PMID 17640955 DOI: 10.1124/Dmd.107.016261 |
0.319 |
|
| 2007 |
Mills EM, Weaver KL, Abramson E, Pfeiffer M, Sprague JE. Influence of dietary fats on Ecstasy-induced hyperthermia. British Journal of Pharmacology. 151: 1103-8. PMID 17533413 DOI: 10.1038/Sj.Bjp.0707312 |
0.302 |
|
| 2007 |
Sprague JE, Yang X, Sommers J, Gilman TL, Mills EM. Roles of norepinephrine, free Fatty acids, thyroid status, and skeletal muscle uncoupling protein 3 expression in sympathomimetic-induced thermogenesis. The Journal of Pharmacology and Experimental Therapeutics. 320: 274-80. PMID 17012607 DOI: 10.1124/Jpet.106.107755 |
0.64 |
|
| 2006 |
Peterson AL, Gilman TL, Banks ML, Sprague JE. Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Synapse (New York, N.Y.). 59: 317-9. PMID 16421905 DOI: 10.1002/Syn.20244 |
0.641 |
|
| 2005 |
Rusyniak DE, Sprague JE. Toxin-induced hyperthermic syndromes. The Medical Clinics of North America. 89: 1277-96. PMID 16227063 DOI: 10.1016/J.Mcna.2005.06.002 |
0.317 |
|
| 2005 |
Sprague JE, Moze P, Caden D, Rusyniak DE, Holmes C, Goldstein DS, Mills EM. Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model. Critical Care Medicine. 33: 1311-6. PMID 15942349 DOI: 10.1097/01.Ccm.0000165969.29002.70 |
0.341 |
|
| 2005 |
Rusyniak DE, Tandy SL, Hekmatyar SK, Mills E, Smith DJ, Bansal N, MacLellan D, Harper ME, Sprague JE. The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis. The Journal of Pharmacology and Experimental Therapeutics. 313: 629-39. PMID 15644431 DOI: 10.1124/Jpet.104.079236 |
0.339 |
|
| 2004 |
Mills EM, Rusyniak DE, Sprague JE. The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine. Journal of Molecular Medicine (Berlin, Germany). 82: 787-99. PMID 15602689 DOI: 10.1007/S00109-004-0591-7 |
0.331 |
|
| 2004 |
Sprague JE, Mallett NM, Rusyniak DE, Mills E. UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermia. Biochemical Pharmacology. 68: 1339-43. PMID 15345323 DOI: 10.1016/J.Bcp.2004.03.049 |
0.369 |
|
| 2004 |
Hrometz SL, Brown AW, Nichols DE, Sprague JE. 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotonin-reuptake transporter, and monoamine oxidase-B. Neuroscience Letters. 367: 56-9. PMID 15308297 DOI: 10.1016/J.Neulet.2004.05.075 |
0.326 |
|
| 2003 |
Mills EM, Banks ML, Sprague JE, Finkel T. Pharmacology: uncoupling the agony from ecstasy. Nature. 426: 403-4. PMID 14647371 DOI: 10.1038/426403A |
0.327 |
|
| 2003 |
Sprague JE, Preston AS, Leifheit M, Woodside B. Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiology & Behavior. 79: 281-7. PMID 12834800 DOI: 10.1016/S0031-9384(03)00092-1 |
0.337 |
|
| 2003 |
Sprague JE, Banks ML, Cook VJ, Mills EM. Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy). The Journal of Pharmacology and Experimental Therapeutics. 305: 159-66. PMID 12649364 DOI: 10.1124/Jpet.102.044982 |
0.428 |
|
| 2002 |
Kanthasamy A, Sprague JE, Shotwell JR, Nichols DE. Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum. Neuroscience. 114: 917-24. PMID 12379247 DOI: 10.1016/S0306-4522(02)00368-8 |
0.413 |
|
| 2002 |
Falk EM, Cook VJ, Nichols DE, Sprague JE. An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA. Pharmacology, Biochemistry, and Behavior. 72: 617-22. PMID 12175458 DOI: 10.1016/S0091-3057(02)00728-1 |
0.419 |
|
| 2002 |
Sprague JE, Leifheit M, Selken J, Milks MM, Kinder DH, Nichols DE. In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol. Synapse (New York, N.Y.). 43: 118-21. PMID 11754490 DOI: 10.1002/Syn.10025 |
0.422 |
|
| 1996 |
Sprague JE, Johnson MP, Schmidt CJ, Nichols DE. Studies on the mechanism of p-chloroamphetamine neurotoxicity. Biochemical Pharmacology. 52: 1271-7. PMID 8937435 DOI: 10.1016/0006-2952(96)00482-0 |
0.367 |
|
| 1996 |
Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE. Reinforcing effects of certain serotonin-releasing amphetamine derivatives. Pharmacology, Biochemistry, and Behavior. 53: 99-105. PMID 8848466 DOI: 10.1016/0091-3057(95)00205-7 |
0.418 |
|
| 1995 |
Marona-Lewicka D, Rhee GS, Sprague JE, Nichols DE. Psychostimulant-like effects of p-fluoroamphetamine in the rat. European Journal of Pharmacology. 287: 105-13. PMID 8749023 DOI: 10.1016/0014-2999(95)00478-5 |
0.387 |
|
| 1995 |
Sprague JE, Nichols DE. Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum. Psychopharmacology. 118: 357-9. PMID 7542394 DOI: 10.1007/Bf02245967 |
0.359 |
|
| 1994 |
Sprague JE, Huang X, Kanthasamy A, Nichols DE. Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurotoxicity with the serotonin precursors tryptophan and 5-hydroxytryptophan. Life Sciences. 55: 1193-8. PMID 7934616 DOI: 10.1016/0024-3205(94)00658-X |
0.346 |
|
| 1993 |
Zabik JE, Sprague JE, Odio M. Interactive dopaminergic and noradrenergic systems in the regulation of thirst in the rat Physiology and Behavior. 54: 29-33. PMID 8392208 DOI: 10.1016/0031-9384(93)90039-I |
0.407 |
|
| 1993 |
Sprague JE, Suckow MA, Fitzgerald AL, Grigdesby CF, Uetrecht RL, Maickel RP. Pharmacological studies of centrifugation-induced analgesia Pharmacology, Biochemistry and Behavior. 46: 911-915. PMID 8309971 DOI: 10.1016/0091-3057(93)90221-E |
0.305 |
|
| Show low-probability matches. |